Evaluation of E2F3 and survivin expression in peripheral blood as potential diagnostic markers of prostate cancer
Background Prostate cancer (PC) incidence has risen globally. As there are no current independent biomarkers with high diagnostic efficiency to detect PC, this study was performed to investigate the relative gene expression levels of E2F3 and survivin in the whole blood of PC, benign prostate hyperplasia (BPH), and normal control individuals and to explore their diagnostic value. Material and methods Participants of the study were divided into three groups; normal control group (n=25), BPH patients (n=25), and PC patients (n=75). The E2F3 and survivin gene expression levels were assessed using real-time qPCR in addition to the measurement of free and total levels of prostate-specific antigen (PSA) using electrochemiluminescence assays. Results Survivin relative gene expression was over-expressed in PC and BPH patients compared to the normal control group, whereas, E2F3 did not differ significantly among the studied groups. Compared to PSA, E2F3 and survivin mRNA expression levels had lower diagnostic efficacy to differentiate PC from normal and BPH individuals with an area under curve (AUC) of 0.471 and 0.727, respectively. Further, survivin expression level was associated with increased the risk of PC. Conclusion Survivin and E2F3 relative expression levels in peripheral blood had low diagnostic performance to detect PC and individuals with high survivin expression levels may have higher risk to develop PC..
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2020 |
|---|---|
| Erschienen: |
2020 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:45 |
|---|---|
| Enthalten in: |
Turkish journal of biochemistry - 45(2020), 5 vom: 12. Juli, Seite 525-532 |
| Beteiligte Personen: |
Wadaa Allah, Ahmed M. [VerfasserIn] |
|---|
| Links: |
Volltext [lizenzpflichtig] |
|---|
| BKL: |
|---|
| Anmerkungen: |
© 2020 Walter de Gruyter GmbH, Berlin/Boston |
|---|
| doi: |
10.1515/tjb-2019-0323 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
GRUY007256019 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | GRUY007256019 | ||
| 003 | DE-627 | ||
| 005 | 20231205155820.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 230811s2020 xx |||||o 00| ||und c | ||
| 024 | 7 | |a 10.1515/tjb-2019-0323 |2 doi | |
| 035 | |a (DE-627)GRUY007256019 | ||
| 035 | |a (DE-B1597)tjb-2019-0323-e | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 082 | 0 | 4 | |a 540 |q VZ |
| 084 | |a 35.70 |2 bkl | ||
| 100 | 1 | |a Wadaa Allah, Ahmed M. |e verfasserin |0 (orcid)0000-0002-9678-7359 |4 aut | |
| 245 | 1 | 0 | |a Evaluation of E2F3 and survivin expression in peripheral blood as potential diagnostic markers of prostate cancer |
| 264 | 1 | |c 2020 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a © 2020 Walter de Gruyter GmbH, Berlin/Boston | ||
| 520 | |a Background Prostate cancer (PC) incidence has risen globally. As there are no current independent biomarkers with high diagnostic efficiency to detect PC, this study was performed to investigate the relative gene expression levels of E2F3 and survivin in the whole blood of PC, benign prostate hyperplasia (BPH), and normal control individuals and to explore their diagnostic value. Material and methods Participants of the study were divided into three groups; normal control group (n=25), BPH patients (n=25), and PC patients (n=75). The E2F3 and survivin gene expression levels were assessed using real-time qPCR in addition to the measurement of free and total levels of prostate-specific antigen (PSA) using electrochemiluminescence assays. Results Survivin relative gene expression was over-expressed in PC and BPH patients compared to the normal control group, whereas, E2F3 did not differ significantly among the studied groups. Compared to PSA, E2F3 and survivin mRNA expression levels had lower diagnostic efficacy to differentiate PC from normal and BPH individuals with an area under curve (AUC) of 0.471 and 0.727, respectively. Further, survivin expression level was associated with increased the risk of PC. Conclusion Survivin and E2F3 relative expression levels in peripheral blood had low diagnostic performance to detect PC and individuals with high survivin expression levels may have higher risk to develop PC. | ||
| 700 | 1 | |a Abdel Hamid, Fatma F. |4 aut | |
| 700 | 1 | |a Soliman, Ahmed F. |4 aut | |
| 700 | 1 | |a Ibrahim, Noha |4 aut | |
| 700 | 1 | |a Malash, Ibrahim |4 aut | |
| 700 | 1 | |a Abdelgawad, Iman A. |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Turkish journal of biochemistry |d De Gruyter, 2006 |g 45(2020), 5 vom: 12. Juli, Seite 525-532 |h Online-Ressource |w (DE-627)GRUY000024651 |w (DE-600)2244112-8 |w (DE-576)281315086 |x 1303-829X |7 nnns |
| 773 | 1 | 8 | |g volume:45 |g year:2020 |g number:5 |g day:12 |g month:07 |g pages:525-532 |
| 856 | 4 | 0 | |u https://dx.doi.org/10.1515/tjb-2019-0323 |z lizenzpflichtig |3 Volltext |
| 912 | |a GBV_GRUY | ||
| 912 | |a SSG-OLC-PHA | ||
| 936 | b | k | |a 35.70 |j Biochemie: Allgemeines |q VZ |
| 951 | |a AR | ||
| 952 | |d 45 |j 2020 |e 5 |b 12 |c 07 |h 525-532 | ||